ARCHIVES

Recalcitrant Cancer Bill Heading To Senate May Face Hold in the Lame Duck Session

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

Trials show No Advantage for ABMT In Breast Cancer; Should Insurers Pay?

April 16, 1999

Clinical Trial Participants Sue Duke University, Potti, Nevins and Others for Causing Harm

September 9, 2011

Mace Rothenberg Leaves Vanderbilt For Pfizer Oncology.

November 14, 2008

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

Two New Modalities Promising For Relapsed/Refractory NHL

January 28, 2005

In Brief: AACR Voted On Naming Delegates To Congress, Not On Attending; ACCC Membership Over 300

February 17, 1978